Literature DB >> 24803775

Airway management of a child with frontometaphyseal dysplasia (Gorlin Cohen syndrome).

Anuradha Ganigara1, Madhavi Nishtala1, Yabagodu Rama Vakoda Chandrika1, Kunigal Ravishankar Chandrakala1.   

Abstract

Frontometaphyseal dysplasia (FMD), also called Gorlin-Cohen syndrome, is a rare hereditary X-linked dominant craniotubular bone disorder. The presentation describes the airway management of a 2-year-old child suffering from FMD with significant retrognathia, posted for major long bone corrective osteotomy. Induction with a combination of dexmedetomidine and ketamine preceded a successful endotracheal intubation under spontaneous ventilation.

Entities:  

Keywords:  Dexmedetomidine; difficult airway; frontometaphyseal dysplasia; ketamine

Year:  2014        PMID: 24803775      PMCID: PMC4009657          DOI: 10.4103/0970-9185.130100

Source DB:  PubMed          Journal:  J Anaesthesiol Clin Pharmacol        ISSN: 0970-9185


Introduction

Frontometaphyseal dysplasia (FMD), also called Gorlin Cohen syndrome, is a hereditary X-linked dominant syndrome described in 1969 with less than 30 cases described in the literature.[12] This case report of a child with FMD is presented owing to the rarity of the syndrome and the anticipated difficult airway, which was successfully managed by using a combination of dexmedetomidine and ketamine while preserving spontaneous ventilation.

Case Report

A 2-year-old female child, a known case of FMD, presented for open reduction of the left hip with osteotomy of femur. Physical examination revealed a slender undernourished girl of 8 kg with prominent supraorbital ridges, ocular hypertelorism, low set ears and a wide bridge nose with prominent eyes. Airway examination revealed a Mallampatti score of III with significant retrognathia, high arched palate with malocclusion of teeth. In addition, she had dorsolumbar scoliosis, pectus carinatum, bowing of long bones with distal phalangeal hypoplasia and multiple joint dislocations [Figure 1].
Figure 1

X-ray lateral view

X-ray lateral view Pre-operative blood investigations, echocardiography and chest X-ray were within physiological limits. Oral midazolam 4 mg was selected for premedication. On arrival to the operation theatre, monitors were connected and child pre-oxygenated for 5 minutes. Injection dexmedetomidine 1 μg/kg was administered for 10 min and then a continuous infusion at 1 μg/kg/h was set for the duration of the remaining procedure. Ketamine was administered in increments of 5 mg up to 12 mg until there was no response to jaw thrust while ensuring spontaneous respiration. Just before direct laryngoscopy intravenous lignocaine 12 mg was administered. Rigid laryngoscopy with Miller 1 straight blade offered a Grade IV Cormack and Lehane view. An additional dose of ketamine 5 mg was administered. After optimal external laryngeal manipulation, the visible glottic chink was sprayed with topical lignocaine and tracheal intubation was successfully performed using an uncuffed 4 sized endotracheal tube. Anesthesia was continued with N2O in 40% O2 along with a continuous Dexmedetomidine and atracurium infusion. Adequate padding was provided at pressure points and extreme caution was exercised during positioning. At the end of the surgery tracheal extubation was successful.

Discussion

FMD belongs to the otopalatodigital spectrum syndromes that includes four phenotypically related conditions, otopalatodigital syndrome Types 1 and 2, FMD and Melnick-Needles syndrome.[12] The most common manifestations include supraorbital hyperostosis, hypertelorism, down-slanting palpebral fissures, broad nasal bridge and micrognathia with anomalies of teeth and generalized skeletal dysplasia. Congenital heart disease, subglottic tracheal narrowing and genitourinary anomalies, muscular hypotonia.[34] Micrognathia, microstomia and malocclusion of teeth may make direct laryngoscopy impossible; therefore, a well-planned airway strategy is mandatory. Ketamine combined with dexmedetomidine was selected for induction of anesthesia. Ketamine was preferred in our case of anticipated difficult airway due to it's inherent sympathomimetic actions devoid of respiratory depression alongwith provision of excellent analgesia and amnesia.[567] Dexmedetomidine a specific and selective ά2-adrenoceptor agonist known for its sedative, anxiolytic, analgesic properties was used to complement ketamine. At the same time dexmedetomidine offsets the sympathomimetic effects of ketamine, also decreases the sialorrhea and emergence delirium associated with ketamine.[89] This unique pharmacological combination in the present case preserved the respiratory drive, allowed maintenance of a patent airway and provided sufficient sedation, analgesia and anesthesia to allow successful airway control. In addition, topical lignocaine was used as per recommendation of Aroni et al.[5] which states that ketamine does not depress coughing or swallowing reflexes. Available literature describes the use of combination of both these drugs in children during procedural anesthesia and not as a complete anesthesia protocol in a challenging case.[10] The present experience of using this combination successfully paves the way to emerging new solutions for management of a difficult pediatric airway. Hence safety profile, rapid onset of action with adequate sedation and analgesia provided by the ketamine and dexmedetomidine make them a distinctive drug combination in the pediatric difficult airway situation in a child with FMD.
  9 in total

Review 1.  Unique clinical situations in pediatric patients where ketamine may be the anesthetic agent of choice.

Authors:  Christopher Jamora; Mohamad Iravani
Journal:  Am J Ther       Date:  2010 Sep-Oct       Impact factor: 2.688

Review 2.  Dexmedetomidine and ketamine: an effective alternative for procedural sedation?

Authors:  Joseph D Tobias
Journal:  Pediatr Crit Care Med       Date:  2012-07       Impact factor: 3.624

Review 3.  Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology.

Authors:  Joseph D Tobias
Journal:  Pediatr Crit Care Med       Date:  2007-03       Impact factor: 3.624

4.  Frontometaphyseal dysplasia. A new syndrome.

Authors:  R J Gorlin; M M Cohen
Journal:  Am J Dis Child       Date:  1969-09

5.  Otopalatodigital syndrome spectrum disorders: otopalatodigital syndrome types 1 and 2, frontometaphyseal dysplasia and Melnick-Needles syndrome.

Authors:  Stephen P Robertson
Journal:  Eur J Hum Genet       Date:  2006-08-23       Impact factor: 4.246

6.  The anaesthetic management of an infant with frontometaphyseal dysplasia (Gorlin-Cohen syndrome).

Authors:  Y Mehta; H Schou
Journal:  Acta Anaesthesiol Scand       Date:  1988-08       Impact factor: 2.105

7.  Dexmedetomidine and ketamine for fiberoptic intubation in a child with severe mandibular hypoplasia.

Authors:  Mohamad Iravani; Samuel H Wald
Journal:  J Clin Anesth       Date:  2008-09       Impact factor: 9.452

8.  The evolution of ketamine applications in children.

Authors:  James A Roelofse
Journal:  Paediatr Anaesth       Date:  2009-09-30       Impact factor: 2.556

9.  Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug.

Authors:  Filippia Aroni; Nicoletta Iacovidou; Ismene Dontas; Chryssa Pourzitaki; Theodoros Xanthos
Journal:  J Clin Pharmacol       Date:  2009-06-22       Impact factor: 3.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.